تحميل...
Levocarnitine for valproate-induced hyperammonemia in the psychiatric setting: A case series and literature review
INTRODUCTION: Hyperammonemia is a potential adverse effect of valproic acid (VPA) therapy, which is often asymptomatic but can lead to severe, life-threatening encephalopathy. Carnitine deficiency due to VPA is the proposed mechanism for hyperammonemia and the development of VPA-induced hyperammonem...
محفوظ في:
| الحاوية / القاعدة: | Ment Health Clin |
|---|---|
| المؤلفون الرئيسيون: | , , |
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
College of Psychiatric & Neurologic Pharmacists
2018
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6007637/ https://ncbi.nlm.nih.gov/pubmed/29955560 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9740/mhc.2018.05.148 |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|